Bos Jl

472 total citations
13 papers, 390 citations indexed

About

Bos Jl is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Bos Jl has authored 13 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in Bos Jl's work include Chronic Myeloid Leukemia Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Bos Jl is often cited by papers focused on Chronic Myeloid Leukemia Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Bos Jl collaborates with scholars based in Netherlands, United Kingdom and United States. Bos Jl's co-authors include W. Kruijer, Maikel P. Peppelenbosch, Hans van Dam, LA Smets, R Släter, Rienk Offringa, H. Behrendt, Sjoerd Rodenhuis, M. van ‘t Veer and W. Keijzer and has published in prestigious journals such as Blood, PubMed and Arthritis Research.

In The Last Decade

Bos Jl

13 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bos Jl Netherlands	10	256	118	68	53	51	13	390
Mahvash Sigaroudinia United States	10	297 1.2×	155 1.3×	45 0.7×	93 1.8×	45 0.9×	13	491
Sharon Olson United States	5	236 0.9×	149 1.3×	72 1.1×	92 1.7×	46 0.9×	7	425
John Smith United Kingdom	3	293 1.1×	176 1.5×	94 1.4×	121 2.3×	12 0.2×	5	444
Stephanie L. Kelich United States	8	207 0.8×	122 1.0×	47 0.7×	103 1.9×	47 0.9×	10	561
Andrea Behrens Germany	8	244 1.0×	143 1.2×	32 0.5×	99 1.9×	26 0.5×	9	478
Athanasios Kotsinas Greece	9	350 1.4×	121 1.0×	59 0.9×	93 1.8×	10 0.2×	15	482
Egon Durban United States	11	254 1.0×	57 0.5×	41 0.6×	14 0.3×	16 0.3×	16	533
Maryann Mikhail United States	9	158 0.6×	140 1.2×	18 0.3×	94 1.8×	24 0.5×	16	365
Paul Glover United States	13	250 1.0×	230 1.9×	64 0.9×	147 2.8×	68 1.3×	17	634
Guylène Bertrand France	11	179 0.7×	108 0.9×	93 1.4×	47 0.9×	6 0.1×	16	408

Countries citing papers authored by Bos Jl

Since Specialization

Citations

This map shows the geographic impact of Bos Jl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bos Jl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bos Jl more than expected).

Fields of papers citing papers by Bos Jl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bos Jl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bos Jl. The network helps show where Bos Jl may publish in the future.

Co-authorship network of co-authors of Bos Jl

This figure shows the co-authorship network connecting the top 25 collaborators of Bos Jl. A scholar is included among the top collaborators of Bos Jl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bos Jl. Bos Jl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Jl, Bos, et al.. (2002). Deregulated Ras and Rap1 signaling in rheumatoid arthritis T cells leads to persistent production of free radicals. Arthritis Research. 4(Suppl 1). 52–52. 4 indexed citations

2.

Peppelenbosch, Maikel P., et al.. (1995). UV activation of receptor tyrosine kinase activity.. PubMed. 11(3). 561–9. 137 indexed citations

3.

Ellis, Charles A., et al.. (1993). Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling.. PubMed. 8(10). 2773–80. 15 indexed citations

4.

Polakis, Paul, et al.. (1992). Association of a tyrosine kinase activity with GAP complexes in v-src transformed fibroblasts.. PubMed. 7(2). 389–94. 13 indexed citations

5.

Kamp, H van, Matty Verlaan–de Vries, Bos Jl, et al.. (1992). Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears. Blood. 79(5). 1266–1270. 2 indexed citations

6.

Meijer, Ingeborg, et al.. (1991). Co-regulated expression of junB and MHC class I genes in adenovirus-transformed cells.. PubMed. 6(6). 911–6. 9 indexed citations

7.

Dam, Hans van, et al.. (1989). The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1.. PubMed. 4(10). 1207–12. 41 indexed citations

8.

Keijzer, W., et al.. (1989). Activated ras genes in human seminoma: evidence for tumor heterogeneity.. PubMed. 4(11). 1345–51. 43 indexed citations

9.

Jl, Bos, et al.. (1988). Activation of N-ras induced by ultraviolet irradiation in vitro.. PubMed. 3(1). 9–20. 41 indexed citations

10.

Jl, Bos. (1988). Ras oncogenes in hematopoietic malignancies.. PubMed. 2(2). 55–63. 19 indexed citations

11.

Jl, Bos, et al.. (1987). Mutations in N-ras predominate in acute myeloid leukemia. Blood. 69(4). 1237–1241. 20 indexed citations

12.

Rodenhuis, Sjoerd, Bos Jl, R Släter, et al.. (1986). Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood. 67(6). 1698–1704. 42 indexed citations

13.

Jl, Bos, et al.. (1986). Absence of oncogene amplifications and occasional activation of N-ras in lymphoblastic leukemia of childhood. Blood. 67(6). 1698–1704. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact